Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Net Cash Flow (2016 - 2025)

CV Sciences' Net Cash Flow history spans 14 years, with the latest figure at -$545000.0 for Q3 2025.

  • For Q3 2025, Net Cash Flow fell 208.57% year-over-year to -$545000.0; the TTM value through Sep 2025 reached -$681000.0, down 2.87%, while the annual FY2024 figure was -$896000.0, 226.91% down from the prior year.
  • Net Cash Flow for Q3 2025 was -$545000.0 at CV Sciences, down from $84000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $1.1 million in Q1 2021 and bottomed at -$2.7 million in Q2 2021.
  • The 5-year median for Net Cash Flow is -$184000.0 (2024), against an average of -$222368.4.
  • The largest YoY upside for Net Cash Flow was 1168.09% in 2024 against a maximum downside of 734.95% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$285000.0 in 2021, then tumbled by 85.26% to -$528000.0 in 2022, then surged by 38.26% to -$326000.0 in 2023, then crashed by 71.78% to -$560000.0 in 2024, then grew by 2.68% to -$545000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Net Cash Flow are -$545000.0 (Q3 2025), $84000.0 (Q2 2025), and $340000.0 (Q1 2025).